Infection Risk in Dermatology Patients Receiving Next-Generation Medication: A Meta-Analysis of JAK Inhibitors and Biologics.

Medicina (Kaunas) · 2025 · PMC12654054 · PMID 41303888

Europe PMC DOI

hedged sentence

0.0523

closest p · 1.0× alpha

0.0523

boldest claim

The sentences

a trend towards significancep = 0.0523so close (0.05 < p ≤ 0.1)

This was mainly in those receiving JAK1- and TYK2-selective drugs; however, we also observed a trend towards significance in those receiving non-selective JAKI ( p = 0.0523), which may warrant further investigation in the future.

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.